# Irbesartan and Hydrochlorothiazide

NDC: 0054-0255
Generic name: Irbesartan and Hydrochlorothiazide
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20121015

FDA application: ANDA090351

## Active ingredients

- HYDROCHLOROTHIAZIDE: 12.5 mg/1
- IRBESARTAN: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0054-0255"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0054-0255
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17561aae-f0bc-4ffc-a007-985b17e9baf0